Health + care

2008 - OECD countries spent nearly $2.8trn on healthcare services US = $1.1trn, UK = $160bn.

2009 projections were that in 2020 - OECD countries = $10trn pa,US = 21% of its GDP, Rest of the OECD countries = 16% GDP (average).

Reality 2009-2011 annual growth only 0.2% (OECD avg)

% GDP spent on health

Why Health + care

Measuring patient outcomes is going to be critical and requires new ways of doing business

so cash is tight....................................

Current healthcare models are unsustainable –delivering efficiency and effectiveness will be the major driver

Health and care cannot be delivered in isolation –collaboration between Healthcare providers, Governments, patients and industry working together to assess and measure outcomes.

SMIP

Stratified Medicine Assisted living

Regenmedand

Cell Therapy

BiomedicalCatalyst

SBRI

Health + care activities Cell

Therapy Catapult

Precision Medicine Catapult

SMIP

Stratified medicine(data integration/adoption)

Independent living(interoperability)

Regenmedand

Cell Therapy(manufacture/

Regulation)

BiomedicalCatalyst

SBRI

Health + Care opportunities

AMR?

BiomedicalCatalyst

SBRI

Healthier livesPrevention

Monitoring?

Antimicrobial ResistanceDementia?

Cell Therapy Catapult

Precision Medicine Catapult

Health + care business models

Business to BusinessNHS social care interventions

Intermediary Community Services

Business to CustomerPrevention Wellness

and self management

Informal Care systems